Oxygenobarotherapy in the complex treatment of patients with a new coronavirus infection COVID-19

Objective: to evaluate the effectiveness of the use of oxygen-barotherapy in the complex treatment of patients with a new coronavirus infection COVID-19 with lung tissue damage.
Materials and methods: 20 patients were examined with a diagnosis of «Coronavirus infection caused by the SARSCoV-2 virus» (moderate patients (CT 1–2)), of which 10 patients were prescribed a course of oxygenobarotherapy together with conservative treatment, and 10 patients received only conservative treatment. The sessions were carried out in the BDK-1400 pressure chamber based on the MAB at 1.7 ATA mode using IVS masks for oxygen breathing for no more than 50 minutes. In total, patients received 7–10 sessions of oxygenobarotherapy. Blood oxygen saturation was measured before and after each session. Statistical analysis of the data was carried out by comparing the studied groups using the Student’s t-test and the Wilcoxon test.
Results and discussion. А course of oxygenobarotherapy was used, consisting in using the 1,7 ATA mode with an exposure of 30 to 50 minutes during the course to achieve maximum therapeutic effect and comfort for the patient. Against the background of the course of oxygenobarotherapy in patients, an increase in blood oxygen saturation in patients of the main group was noted, as well as positive dynamics in the form of a decrease and cessation of shortness of breath and cough, improvement of general well-being.